Healthtech Startups

ANNA Autism Care provides ABA therapy for autistic children using Naturalistic Developmental Behavioral Intervention alongside parent coaching. It offers intervention services and insurance support, accepting most major insurance providers including Medicaid.

3 investors

Annexon is a clinical-stage biopharmaceutical company developing C1q and classical complement pathway inhibitors to treat complement-mediated autoimmune, neurodegenerative, and ophthalmic disorders. Its pipeline targets diseases of the body, brain, and eye, including Guillain-Barré syndrome and geographic atrophy.

3 investors

Anodyne Nanotech develops the HeroPatch, a transdermal drug delivery system designed to replace traditional injections for chronic care treatments. The company focuses on simplifying medicine delivery through an alternative to needles and syringes.

3 investors

Anonymous Health connects people in addiction recovery with care providers, supporting them through ongoing conversations and relationships. It operates in the digital health space with a focus on recovery and mental health support.

3 investors

Antag Therapeutics develops GIP receptor antagonist therapies for obesity, diabetes, and overweight patients. The company's lead candidate, AT-7687, is a clinical-stage peptide designed to block dysfunctional biological pathways contributing to fat storage and metabolic dysfunction, offering an alternative treatment approach with improved tolerability.

3 investors

Antara is a healthcare company operating a care coordination model, with a team spanning product, operations, and care coordination functions.

3 investors

Aperture Bio develops technologies to translate human tumor biology in order to reduce risk in preclinical drug development.

3 investors

Aplagon is a clinical-stage biopharmaceutical company developing first-in-class therapeutics targeting thromboinflammatory and cardiovascular diseases. The company's lead candidate, APAC, is a heparin proteoglycan mimetic currently in clinical trials.

3 investors

Apogee Therapeutics develops engineered antibody therapies to treat inflammatory and immune diseases with reduced injection frequency compared to existing treatments.

3 investors

Apollo Neuro makes a wearable device that delivers gentle vibrations ("SmartVibes") intended to balance the autonomic nervous system, aiming to reduce stress, improve sleep, focus, and recovery. Developed by physicians and neuroscientists and backed by clinical research, the consumer product is worn on the wrist, ankle, or clipped to clothing and paired with a subscription app.

3 investors

A portfolio biopharmaceutical company translating basic medical research breakthroughs from leading universities into novel therapeutic medicines. The company develops a diversified pipeline of drug candidates through partnerships with top research institutions and selective in-licensing of clinical-stage programs.

3 investors

Append Medical develops a transcatheter system using vacuum-based technology to treat non-valvular atrial fibrillation by occluding the left atrial appendage without implanting a device in the heart. The system aims to reduce stroke risk in cardiac patients by eliminating device-related thromboembolism and peri-device leakage complications.

3 investors

Apprentice Health builds software that uses ambient sensors, AI, and simulation to manage clinical workflow, room allocation, and patient communication, helping care teams reduce patient wait times and optimize exam room usage. Its modules serve clinics, infusion suites, peri-operative units, emergency departments, and inpatient units.

3 investors

APR is a South Korean beauty-tech company that develops and manufactures beauty devices (such as EMS, HIFU, and radio-frequency skincare devices under its Medicube AGE-R line) alongside cosmetics, fragrance, and fashion brands including APRILSKIN, Medicube, Forment, and NERDY. The company sells through its own direct-to-consumer online stores and operates internationally with subsidiaries across Asia and the US.

3 investors

Arbital Health provides a platform for managing value-based care (VBC) contracts, unifying claims, utilization, benchmark, and contract data with actuarial tools, predictive models, and a conversational "Actuarial AI" for real-time performance monitoring and risk analysis. It serves healthcare organizations and value-based care teams, pairing its software with dedicated VBC actuary expertise.

3 investors

ArborMetrix provides a software platform for healthcare quality improvement that aggregates and analyzes patient data to help providers, payers, and health systems optimize clinical and financial performance, reduce adverse events, and improve outcomes. The platform enables real-time insights and predictive analytics to guide clinical decisions and operational efficiency.

3 investors

Arbutus Medical develops FDA-cleared surgical devices for orthopedic trauma procedures, including innovative drill technology and sterile-packed procedure kits designed for use in low-resource hospitals globally.

3 investors

Atlas is a vendor evaluation platform for healthcare organizations to search, compare, and rank healthcare technology solutions across categories like telehealth and AI clinical tools, using clinical evidence and real-world outcomes data.

3 investors

Arcutis is a biopharmaceutical company focused on dermatology, developing treatments for immune-mediated skin diseases such as plaque psoriasis, atopic dermatitis, seborrheic dermatitis, and scalp psoriasis. It serves patients and healthcare professionals with therapies aimed at improving drug efficacy, safety, and tolerability.

3 investors

Argá Medtech is developing a non-thermal cardiac ablation system based on a proprietary Pulsed Field Ablation (PFA) technology using sine wave energy and a proprietary catheter to treat atrial fibrillation and other heart arrhythmias. The system targets electrophysiology and interventional cardiology, aiming to improve the safety, speed, and long-term outcomes of cardiac ablation.

3 investors

Argon AI provides an AI-native workspace designed for life sciences, clinical, and commercial teams that automates research workflows, generates insights from medical data, and accelerates drug development processes.

3 investors

Arialys Therapeutics develops precision medicines designed to block pathogenic autoantibodies that target brain receptors such as the NMDA receptor, aiming to treat neuropsychiatric disorders driven by autoimmune disease. It focuses on autoimmune neuropsychiatry, addressing conditions including encephalitis, schizophrenia, dementia, and cancer-related cognitive impairment.

3 investors

Arima Genomics develops DNA-based cancer diagnostics that combine genomic sequence with 3D genome structural information (via Hi-C sequencing) to detect fusions, rearrangements, ecDNA, and other structural drivers of cancer. It serves clinicians and biopharma partners through its Aventa clinical testing brand and translational science collaborations, using routine FFPE tumor samples to guide diagnosis and therapy selection.

3 investors

ARIZ Precision Medicine develops cancer treatments that combine biological and nanotechnology approaches to target the genetic and epigenetic drivers of cancer, aiming to kill cancer cells while leaving healthy cells undamaged. The company designs targeted drug delivery systems intended to concentrate drugs inside cancer cells.

3 investors